← Open Payments lookup

MEGAN THOMPSON: Open Payments

NPI 1851992549 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$620 in 35 payments from 12 companies in 2025. Trend: 2023 $135 · 2024 $276 · 2025 $620

Food & beverage: $620
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$112
Lilly USA, LLC5$79
Novo Nordisk Inc5$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
Sumitomo Pharma America, Inc.3$55
Esperion Therapeutics, Inc.3$51
Amgen Inc.3$45
ABBVIE INC.2$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$38
GlaxoSmithKline, LLC.1$22

Products named: JARDIANCE, CAPLYTA, FARXIGA, GEMTESA, NEXLETOL, Wegovy, QULIPTA, BREZTRI.

Industry payments across MS — which companies pay providers there.